COST-EFFECTIVENESS ANALYSIS OF INSULIN DETEMIR VERSUS INSULIN NEUTRAL PROTAMINE HAGEDORN (NPH) IN PATIENTS WITH TYPE 1 DIABETES MELLITUS IN SPAIN

被引：0
|
作者：
Ramirez de Arellano, A. [1 ]
Lizan, L. [2 ]
Prades, M. [2 ]
Morales, C. [3 ]
De Luis, D. [4 ]
机构：
[1] Novo Nordisk Pharma SA, Madrid, Spain
[2] Outcomes 10, Castellon de La Plana, Spain
[3] Hosp Virgen de la Macarena, Seville, Spain
[4] Hosp Rio Hortega, Valladolid, Spain
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB64
引用
收藏
页码：A343 / A343
页数：1
相关论文
共 50 条
  • [21] Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis
    E. Lau
    A. Salem
    J. C. N. Chan
    W. Y. So
    A. Kong
    M. Lamotte
    A. Luk
    Cost Effectiveness and Resource Allocation, 17
  • [22] Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis
    Lau, E.
    Salem, A.
    Chan, J. C. N.
    So, W. Y.
    Kong, A.
    Lamotte, M.
    Luk, A.
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2019, 17 (1)
  • [23] The effects of subcutaneous neutral protamine Hagedorn (NPH) insulin on glucose metabolism following a period of insulin withdrawal in patients with Type 1 diabetes
    Herring, R.
    Shojaee-Moradie, F.
    Jackson, N.
    Jones, R.
    Umpleby, A. M.
    Russell-Jones, D. L.
    DIABETIC MEDICINE, 2013, 30 : 15 - 16
  • [24] SHORT-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR VERSUS NPH INSULIN IN INSULIN-NAIVE SUBJECTS WITH TYPE 2 DIABETES IN SWEDEN
    Ridderstrale, M.
    Ericsson, A.
    Jensen, M. M.
    VALUE IN HEALTH, 2011, 14 (07) : A480 - A480
  • [25] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK
    McEwan, Phil
    Poole, Chris D.
    Tetlow, Tony
    Holmes, Paul
    Currie, Craig J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S7 - S19
  • [26] A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review
    Frier, B. M.
    Russell-Jones, D.
    Heise, T.
    DIABETES OBESITY & METABOLISM, 2013, 15 (11): : 978 - 986
  • [27] Cost-effectiveness analysis of basal-bolus therapy of type 1 diabetes using insulin detemir plus insulin aspart versus NPH plus insulin aspart regimens
    Valentine, WJ
    Wittrup-Jensen, KU
    Häuser, C
    Roze, S
    DIABETOLOGIA, 2005, 48 : A334 - A334
  • [28] Cost-effectiveness analysis of basal-bolus therapy of type 1 diabetes using insulin detemir plus insulin aspart versus NPH plus insulin aspart regimens
    Valentine, WJ
    Wittrup-Jensen, KU
    Palmer, AJ
    Roze, S
    DIABETES, 2005, 54 : A609 - A609
  • [29] A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes
    Hod, Moshe
    Mathiesen, Elisabeth R.
    Jovanovic, Lois
    McCance, David R.
    Ivanisevic, Marina
    Duran-Garcia, Santiago
    Brondsted, Lise
    Nazeri, Avideh
    Damm, Peter
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2014, 27 (01): : 7 - 13
  • [30] Insulin Glargine versus Neutral Protamine Hagedorn Insulin for Treatment of Diabetes in Pregnancy
    Smith, Jennifer G.
    Manuck, Tracy A.
    White, Jenifer
    Merrill, David C.
    AMERICAN JOURNAL OF PERINATOLOGY, 2009, 26 (01) : 57 - 62
12345